4

Back to all posts

Oklahoma State University Begins Clinical Study of RenoVō® Equine Allograft
Renovo Barrel Study Header

Equine Amnio Solutions, LLC (EAS), a distributor of advanced equine allografts derived from equine amniotic tissues, announced today partnership with the Oklahoma State University College of Veterinary Medicine to conduct clinical evaluation of RenoVō® on equine limb wounds.

RenoVō® is an acellular, liquid allograft derived from amniotic tissues and is intended for equine homologous use. Amniotic tissues contain extracellular matrix proteins, growth factors, cytokines, carbohydrates, hyaluronic acid, and other elements which are essential for foal growth and development. Just as the amniotic membrane and fluid provide biologic and physiologic properties and act as a physical barrier during pregnancy, RenoVō® provides physical and physiological properties to cover and protect tissues.

The study, entitled “Efficacy and safety of an equine liquid amniotic tissue allograft on equine distal limb wound healing” is being conducted in conjunction with the university’s Equine Surgery and Sports Medicine faculty.

Lead Investigator Mike J. Schoonover, DVM, MS, DACVS-LA, DACVSMR stated, “Oklahoma State is pleased to partner with EAS and its affiliates in a study of RenoVō®. This is the first of several studies intended to evaluate the safety and clinical performance of the product in common horse injuries.”

RenoVō® donor tissue is recovered following strict guidelines. Donors are healthy mares and tissues are collected without harm to the mare or foal. At the time of delivery, the foal is delivered and the placenta and fluid, which are typically discarded, are saved. RenoVō® is subjected to stringent USP testing prior to release. The product is supplied in volumes of 1.5 cc, 3.0 cc and 5.0 cc.

About Equine Amnio Solutions

Equine Amnio Solutions, LLC (EAS) is the market leader in the distribution of advanced equine allografts derived from equine amniotic tissues. Our mission is to develop and provide innovative products to maximize the health and performance of horses across all breeds and athletic disciplines. For additional information, please visit www.equineamniosolutions.com.

About Oklahoma State University College of Veterinary Medicine

OSU’s College of Veterinary Medicine is one of 30 veterinary colleges in the United States and the only veterinary college in Oklahoma. For more information, visit https://vetmed.okstate.edu.

RenoVō® is a Registered Trademark of Equine Amnio Solutions, LLC.

You may want to read these articles

RenoVō® CASE STUDY: Puncture Wound

RenoVō® CASE STUDY: Puncture Wound

Case presentation - June 9, 2022: A three-year-old Quarter Horse filly backed into the catch for the stall door and punctured herself, creating a large, deep wound on her left thigh. The wound was sutured with internal and external stiches at clinic, however the...

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

Case presentation - June 9, 2016: A 9 year old Warmblood jumping horse presented with a superficial digital flexor tendon injury of the right hind leg. The horse was treated with stem cell injections. After 10 months of rest and rehabilitation, the horse slowly went...

RenoVō® CASE STUDY: Summer Sore

RenoVō® CASE STUDY: Summer Sore

Case presentation - June 17, 2022: A 19-year-old Red Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a large Summer Sore on the commissure of the right side of the mouth. The horse was treated orally with Ivermectin and topically with Ivermectin...